SCHEMBL4863350

SCHEMBL4863350

CC1(C)CCC(C=NOCc2ccccc2)(C(=O)O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
NAMPT P43490 1/20 0.37
ALDH1A1 P00352 5/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
AKR1B10 O60218 2/20 0.36
AKR1B1 P15121 2/20 0.36
CA12 O43570 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
DDB1 Q16531 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4863341 1.00 LMNA (0.38) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4867764 0.88 NAMPT (0.38) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4863361 0.87 LMNA (0.41) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4864690 0.86 LMNA (0.40) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4868008 0.86 LMNA (0.40) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4866100 0.84 ALDH1A1 (0.40) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4863333 0.84 ALDH1A1 (0.40) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4863329 0.84 ALDH1A1 (0.40) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4863343 0.84 ALDH1A1 (0.40) LMNAPPARGPPARANAMPTALDH1A1
SCHEMBL4866777 0.82 METAP2 (0.36) LMNAPPARGPPARANAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332485-B2 Peptide deformylase inhibitors SMITHKLINE BEECHAM CORP (US) 2008-02-19 US disclosed
US-20060160802-A1 Peptide deformylase inhibitors GLAXO GROUP LIMITED 2006-07-20 US disclosed
WO-2005005456-A2 PEPTIDE DEFORMYLASE INHIBITORS GLAXO GROUP LIMITED (GB) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160802-A1 Peptide deformylase inhibitors PDF, PEPD, DPEP1 LMNA 2515/4885PPARG 4526/4885PPARA 4010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.